"Mr\u00E1z, Milo\u0161" . . "Trachta, Pavel" . . . . . "RIV/00064165:_____/10:7197!RIV11-MZ0-00064165" . . "CZ - \u010Cesk\u00E1 republika" . "Vliv 6m\u011Bs\u00ED\u010Dn\u00EDho pod\u00E1v\u00E1n\u00ED exenatidu na kompenzaci diabetes mellitus 2. typu, antropometrick\u00E9 a biochemick\u00E9 parametry" . . "B\u00E1rtlov\u00E1, Mark\u00E9ta" . . "296524" . "Haluz\u00EDk, Martin" . . . . "The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters"@en . . . . "Vliv 6m\u011Bs\u00ED\u010Dn\u00EDho pod\u00E1v\u00E1n\u00ED exenatidu na kompenzaci diabetes mellitus 2. typu, antropometrick\u00E9 a biochemick\u00E9 parametry"@cs . "[0996D7995903]" . "I, Z(MZ0VFN2005)" . "Exenatide, a synthetic GLP-1 analogue, is a new antidiabetic agent from the group of incretine mimetics ciming into the daily clinical practice. In our study we evaluated the effect of 6-monaths treatment with exenatide on diabetes compensation, anthropometric and biochemical parameters in the patients with poorly controlled type 2 diabetes mellitus and obesity."@en . "Vliv 6m\u011Bs\u00ED\u010Dn\u00EDho pod\u00E1v\u00E1n\u00ED exenatidu na kompenzaci diabetes mellitus 2. typu, antropometrick\u00E9 a biochemick\u00E9 parametry"@cs . "Housov\u00E1, Jitka" . "Vliv 6m\u011Bs\u00ED\u010Dn\u00EDho pod\u00E1v\u00E1n\u00ED exenatidu na kompenzaci diabetes mellitus 2. typu, antropometrick\u00E9 a biochemick\u00E9 parametry" . . . "Matoulek, Martin" . "6"^^ . "Exenatid, syntetick\u00FD analog GLP-1, je nov\u00E9 antidiabetikum ze skupiny inkreatinov\u00FDch mimetik, kter\u00E9 je postupn\u011B zav\u00E1d\u011Bno do klinick\u00E9 praxe. V na\u0161\u00ED studii jsme sledovali vliv 6m\u011Bs\u00ED\u010Dn\u00EDho pod\u00E1v\u00E1n\u00ED exenatidu na kompenzaci diabetu, antropometrick\u00E9 a biochemick\u00E9 ukazatele u neuspokojiv\u011B kompenzovan\u00FDch pacient\u016F s diabetes mellitus (DM) 2. typu a obezitou." . "Exenatide; GLP-1; type 2 diabetes mellitus; body weight; obesity"@en . "56" . "Exenatid, syntetick\u00FD analog GLP-1, je nov\u00E9 antidiabetikum ze skupiny inkreatinov\u00FDch mimetik, kter\u00E9 je postupn\u011B zav\u00E1d\u011Bno do klinick\u00E9 praxe. V na\u0161\u00ED studii jsme sledovali vliv 6m\u011Bs\u00ED\u010Dn\u00EDho pod\u00E1v\u00E1n\u00ED exenatidu na kompenzaci diabetu, antropometrick\u00E9 a biochemick\u00E9 ukazatele u neuspokojiv\u011B kompenzovan\u00FDch pacient\u016F s diabetes mellitus (DM) 2. typu a obezitou."@cs . . "10"^^ . . . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . "Sva\u010Dina, \u0160t\u011Bp\u00E1n" . "8"^^ . . "Roub\u00ED\u010Dek, Tom\u00E1\u0161" . . . . "1" . "Kav\u00E1lkov\u00E1, Petra" . "Haluz\u00EDkov\u00E1, Denisa" . "0042-773X" . "The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters"@en . . "RIV/00064165:_____/10:7197" . .